MedPath

Clinical study on multi-channel therapy of traditional Chinese medicine for refractory tubal infertility

Not Applicable
Conditions
Female infertility
Registration Number
ITMCTR2200005734
Lead Sponsor
Fujian Nanping people's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

? Consistent with the diagnosis of refractory infertility;
? Infertility in line with tubal factors and at least one fallopian tube is unobstructed after hysteroscopy;
? Aged 23-40 years, the man's semen examination was normal;
? Informed consent and willingness to cooperate.

Exclusion Criteria

? Infertility combined with other factors;
? Heart, liver, kidney and other important organ diseases;
? Those who are unable to cooperate due to neurological and mental disorders;
? Those who are allergic to the therapeutic drugs of this study (such as Salvia miltiorrhiza powder injection, amikacin, moxa, etc.) or have clear treatment contraindications;
? Those who refuse treatment and refuse to sign informed consent.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intrauterine pregnancy rate;
Secondary Outcome Measures
NameTimeMethod
Recurrence rate of hydrosalpinx;Safety indicators and adverse events / reactions of multi-channel treatment of traditional Chinese Medicine;
© Copyright 2025. All Rights Reserved by MedPath